NCT04753762View on ClinicalTrials.gov

Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

January 1, 2021

Study Completion Date

February 1, 2022

Conditions
COVID-19 Virus DiseaseCardiac Complication
Trial Locations (1)

54500

Laura FILIPPETTI, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT04753762 - Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection | Biotech Hunter | Biotech Hunter